My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Oil India slips over 4% in two sessions
Nov 29,2016

The result was announced during trading hours yesterday, 28 November 2016. Shares of Oil India fell 2.08% to Rs 427.80. The stock has fallen 4.30% in two trading sessions from its close of Rs 436.90 on 25 November 2016.

Meanwhile, the BSE Sensex was up 193.05 points, or 0.73%, to 26,543.22.

On BSE, so far 61,000 shares were traded in the counter, compared with average daily volume of 74,282 shares in the past one quarter. The stock hit a high of Rs 427.15 and a low of Rs 418.05 so far during the day. The stock hit a 52-week high of Rs 446 on 24 November 2016. The stock hit a 52-week low of Rs 300.50 on 1 March 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, rising 2.58% compared with the 5.66% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 11.10% as against Sensexs 7.03% decline.

The large-cap company has equity capital of Rs 601.14 crore. Face value per share is Rs 10.

Oil Indias net profit of declined 17.8% to Rs 580.27 crore on 6.5% decline in net sales to Rs 2242.72 crore in Q2 September 2016 over Q2 September 2015.

Meanwhile, the company said in a separate announcement yesterday, 28 November 2016, that its board recommended issuing one bonus equity share for every three existing fully paid up equity share (1:3). The proposal is subject to approval of the shareholders.

The Government of India held 67.64% stake in Oil India as per the shareholding pattern as on 30 September 2016.

Powered by Capital Market - Live News

Volumes jump at Motilal Oswal Financial Services counter
Nov 29,2016

Motilal Oswal Financial Services clocked volume of 5.20 lakh shares by 13:24 IST on BSE, a 34.12-times surge over two-week average daily volume of 15,000 shares. The stock rose 3.05% to Rs 512.40.

PI Industries notched up volume of 2.04 lakh shares, a 8.62-fold surge over two-week average daily volume of 24,000 shares. The stock fell 0.68% to Rs 874.25.

Suven Life Sciences saw volume of 4.30 lakh shares, a 8.31-fold surge over two-week average daily volume of 52,000 shares. The stock rose 3.95% to Rs 181.40.

Reliance Industrial Infrastructure clocked volume of 2.07 lakh shares, a 5.08-fold surge over two-week average daily volume of 41,000 shares. The stock rose 10.58% to Rs 394.20.

TVS Electronics saw volume of 6.38 lakh shares, a 4.91-fold rise over two-week average daily volume of 1.30 lakh shares. The stock rose 10% to Rs 161.20.

Powered by Capital Market - Live News

Pfizer moves higher after undertaking review of its respiratory portfolio
Nov 29,2016

The announcement was made after market hours yesterday, 28 November 2016.

Meanwhile, the S&P BSE Sensex was up 200.17 points or 0.76% at 26,550.34.

On the BSE, 1,152 shares were traded on the counter so far as against the average daily volumes of 2,553 shares in the past one quarter. The stock had hit a high of Rs 1,850 and a low of Rs 1,818 so far during the day. The stock had hit a 52-week high of Rs 2,540 on 7 December 2015. The stock had hit a 52-week low of Rs 1,611 on 21 March 2016. The stock had outperformed the market over the past one month till 28 November 2016, sliding 0.64% compared with the Sensexs 5.7% fall. The scrip had, however, underperformed the market in past one quarter, declining 7.04% as against the Sensexs 5.15% fall.

The mid-cap company has equity capital of Rs 45.75 crore. Face value per share is Rs 10.

Pfizer has undertaken a comprehensive review of its respiratory offerings to better cover a broader range of indications through an expanded product portfolio. As a result of this review, the company will launch additional products while it may also discontinue the manufacture of certain SKUs where needed.

Pfizer will be launching a series of products as line extensions under the Corex brand name, starting with the first launch in December 2016 and subsequent launches over the next year.

The company has also decided to discontinue the manufacturing of the current Corex Cough Syrup formulation (Codeine Phosphate 10mg + Chlorpheniramine Maleate 4mg).

Pfizer said it stands by the safety and efficacy of its current Corex Cough Syrup formulation that has been duly approved by Central and state regulators. As with this formulation, all additional line extensions will be introduced with all due regulatory approvals in place, it added.

Corex Cough Syrup recorded a sale of Rs 244.48 crore for the financial year ended 31 March 2016.

Pfizers net profit rose 52.5% to Rs 126.33 crore on 4.9% growth in net sales to Rs 530.02 crore in Q2 September 2016 over Q2 September 2015.

Pfizer is a leading biopharmaceutical company.

Powered by Capital Market - Live News

Natco Pharma gains after USFDA approval for generic drug
Nov 29,2016

The announcement was made during trading hours today, 29 November 2016.

Meanwhile, the BSE Sensex was up 174.93 points, or 0.66%, to 26,525.10.

On BSE, so far 25,000 shares were traded in the counter, compared with average daily volume of 30,786 shares in the past one quarter. The stock hit a high of Rs 626 and a low of Rs 612.40 so far during the day. The stock hit a record high of Rs 703.95 on 25 August 2016. The stock hit a 52-week low of Rs 390 on 29 March 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, rising 2.36% compared with the 5.66% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 10.65% as against Sensexs 7.03% decline.

The large-cap company has equity capital of Rs 34.86 crore. Face value per share is Rs 2.

Natco Pharma announced receiving final approval of Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the US Food and Drug Administration (USFDA) for generic version of Armodafinil tablets, 50 milligrams (mg), 150 mg, and 250 mg. Natco and its marketing partner Breckenridge Pharmaceutical, Inc., plan to launch this product in the US market immediately.

Cephalon (acquired by Teva in 2011) sells Armodafinil 50mg, 150mg, and 250mg tablets under brand name NUVUGIL in the US market. NUVUGIL is a wakefulness promoting agent for oral administration. NUVUGIL Tablets had US sales of approximately $480 million for twelve months ending December 2015, according to IMS Health.

On a consolidated basis, net profit of Natco Pharma rose 127.21% to Rs 66.55 crore on 75.56% rise in net sales to Rs 415.21 crore in Q2 September 2016 over Q2 September 2015.

Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.

Powered by Capital Market - Live News

Cox & Kings slips on weak Q2 results
Nov 29,2016

The result was announced after market hours yesterday, 28 November 2016.

Meanwhile, the BSE Sensex was up 190.99 points, or 0.72%, to 26,541.16.

On BSE, so far 80,000 shares were traded in the counter, compared with average daily volume of 1.71 lakh shares in the past one quarter. The stock hit a high of Rs 166.30 and a low of Rs 159.10 so far during the day. The stock hit a 52-week high of Rs 256.45 on 6 January 2016. The stock hit a 52-week low of Rs 140.50 on 17 February 2016. The stock had underperformed the market over the past 30 days till 28 November 2016, falling 26.52% compared with the 5.66% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 12.70% as against Sensexs 7.03% decline.

The small-cap company has equity capital of Rs 88.28 crore. Face value per share is Rs 5.

Cox & Kings is a leading leisure and education travel group with operations in 22 countries across 4 continents.

Powered by Capital Market - Live News

Bharat Financial Inclusion jumps on foreign brokerage rating
Nov 29,2016

Meanwhile, the S&P BSE Sensex was up 177.12 points or 0.67% at 26,527.29.

On BSE, so far 3.08 lakh shares were traded in the counter as against average daily volume of 2.11 lakh shares in the past one quarter. The stock hit a high of Rs 734.50 and a low of Rs 691 so far during the day. The stock had hit a 52-week high of Rs 938.75 on 29 July 2016. The stock had hit a 52-week low of Rs 434.85 on 9 December 2015. The stock had underperformed the market over the past one month till 28 November 2016, sliding 22.94% compared with the Sensexs 5.7% fall. The scrip had also underperformed the market in past one quarter, declining 13.28% as against the Sensexs 5.15% fall.

The mid-cap company has equity capital of Rs 137.91 crore. Face value per share is Rs 10.

The foreign brokerage reportedly said that Bharat Financial Inclusion has collected 89% of its overall dues over the period from 11 November to 25 November 2016.

Bharat Financial Inclusions net profit rose 87.4% to Rs 145.88 crore on 38.6% increase in total income to Rs 449.60 crore in Q2 September 2016 over Q2 September 2015.

Bharat Financial Inclusion is among the largest microfinance companies in India.

Powered by Capital Market - Live News

Surana Solar spurts after winning order
Nov 29,2016

The announcement was made after market hours yesterday, 28 November 2016.

Meanwhile, the BSE Sensex was up 166.80 points, or 0.63%, to 26,516.97.

On BSE, so far 1.04 lakh shares were traded in the counter, compared with average daily volume of 25,420 shares in the past one quarter. The stock hit a high of Rs 25.10 and a low of Rs 23.80 so far during the day. The stock hit a 52-week high of Rs 39.75 on 7 January 2016. The stock hit a 52-week low of Rs 19 on 24 June 2016. The stock had underperformed the market over the past 30 days till 28 November 2016, falling 9.71% compared with the 5.66% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 8.96% as against Sensexs 7.03% decline.

The small-cap company has equity capital of Rs 24.60 crore. Face value per share is Rs 5.

Surana Solar has been awarded an engineering procurement construction (EPC) contract for design, engineering, procurement & supply, construction & erection, testing, commissioning, associated transmission system & comprehensive operation & maintenance for 10 years of a 10 megawatts (MW) (AC) solar power plant by Paradip Port Trust, Odisha (India). The total EPC contract awarded is Rs 60.60 crore and for Operations and Maintenance (O&M) works for ten years is Rs 4.75 crore, which is more than 50% of the turnover of the financial year 2015-2016.

Net profit of Surana Solar rose 7.50% to Rs 0.43 crore on 25.30% decline in net sales to Rs 17.69 crore in Q2 September 2016 over Q2 September 2015.

Surana Solar is one of the leading manufacturers of solar photovoltaic modules in India.

Powered by Capital Market - Live News

Weak Q2 earnings weigh on Hindustan Composites
Nov 29,2016

The result was announced after market hours yesterday, 28 November 2016.

Meanwhile, the S&P BSE Sensex was up 194.91 points or 0.74% at 26,545.08.

On BSE, so far 350 shares were traded in the counter as against average daily volume of 1,326 shares in the past one quarter. The stock hit a high of Rs 1,701 and a low of Rs 1,599 so far during the day. The stock had hit a record high of Rs 2,119 on 20 September 2016. The stock had hit a 52-week low of Rs 750 on 8 April 2016. The stock had underperformed the market over the past one month till 28 November 2016, sliding 12.24% compared with the Sensexs 5.7% fall. The scrip had, however, outperformed the market in past one quarter, advancing 37.05% as against the Sensexs 5.15% fall.

The small-cap company has equity capital of Rs 4.92 crore. Face value per share is Rs 10.

Hindustan Composites is a pioneer in the development, manufacture & marketing of industrial products and friction materials in India.

Powered by Capital Market - Live News

Triveni Engineering & Industries spurts after robust Q2 results
Nov 29,2016

The result was announced after market hours yesterday, 28 November 2016.

Meanwhile, the BSE Sensex was up 199.33 points, or 0.76%, to 26,549.50.

On BSE, so far 3.61 lakh shares were traded in the counter, compared with average daily volume of 1.64 lakh shares in the past one quarter. The stock hit a high of Rs 64.70 and a low of Rs 61.80 so far during the day. The stock hit a 52-week high of Rs 68 on 4 July 2016. The stock hit a 52-week low of Rs 33.90 on 9 December 2015. The stock had outperformed the market over the past 30 days till 28 November 2016, falling 3.52% compared with the 5.66% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 10.19% as against Sensexs 7.03% decline.

The small-cap company has equity capital of Rs 25.79 crore. Face value per share is Re 1.

Triveni Engineering & Industries has core competencies in the areas of sugar and engineering. The company is one amongst the largest sugar manufacturers in India and the market leader in its engineering businesses comprising high speed gears, gearboxes, and water treatment solutions.

Powered by Capital Market - Live News

Sun Pharma slips in volatile trade
Nov 29,2016

The announcement was made after market hours yesterday, 28 November 2016.

Meanwhile, the S&P BSE Sensex was up 98.85 points or 0.38% at 26,449.02.

On BSE, so far 95,000 shares were traded in the counter as against average daily volume of 3.68 lakh shares in the past one quarter. The stock was volatile. The stock lost as much as 1.06% at the days low of Rs 706.20 so far during the day. The stock rose as much as 1.14% at the days high of Rs 721.95 so far during the day. The stock had hit a 52-week high of Rs 898 on 23 February 2016. The stock had hit a 52-week low of Rs 572.40 on 9 November 2016. The stock had outperformed the market over the past one month till 28 November 2016, sliding 4.03% compared with the Sensexs 5.7% fall. The scrip had, however, underperformed the market in past one quarter, declining 5.58% as against the Sensexs 5.15% fall.

The large-cap company has equity capital of Rs 240.68 crore. Face value per share is Rs 1.

A nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery, BromSite will be marketed by Sun Ophthalmics, the companys branded ophthalmic business solution. BromSite is the first branded product launched by the company in the US, following its focus on Specialty business.

On a consolidated basis, Sun Pharmaceutical Industries net profit rose 117.3% to Rs 2235.14 crore on 13.2% growth in net sales to Rs 7764.03 crore in Q2 September 2016 over Q2 September 2015.

Sun Pharmaceutical Industries is the worlds fifth largest specialty generic pharmaceutical company and Indias top pharmaceutical company.

Powered by Capital Market - Live News

Mahanagar Gas firms up after good Q2 earnings
Nov 29,2016

The result was announced after market hours yesterday, 28 November 2016.

Meanwhile, the BSE Sensex was up 117.26 points, or 0.45%, to 26,467.43.

On BSE, so far 1.02 lakh shares were traded in the counter, compared with average daily volume of 75,985 shares in the past one quarter. The stock hit a high of Rs 827.90 and a low of Rs 798.50 so far during the day. The stock hit a record high of Rs 899 yesterday, 28 November 2016. The stock hit a record low of Rs 493.20 on 13 July 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, rising 0.88% compared with the 5.66% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 20.39% as against Sensexs 7.03% decline.

Shares of Mahanagar Gas entered the stock market on 1 July 2016. The mid-cap company has equity capital of Rs 98.78 crore. Face value per share is Rs 10.

Mahanagar Gas (MGL) is one of Indias leading natural gas distribution companies. MGL is a joint venture between GAIL (India) and BGAPH (a subsidiary of Royal Dutch Shell Plc).

Powered by Capital Market - Live News

Timken India jumps after good Q2 results
Nov 29,2016

The result was announced after market hours yesterday, 28 November 2016.

Meanwhile, the BSE Sensex was up 132.30 points, or 0.50%, to 26,482.47.

On BSE, so far 9,770 shares were traded in the counter, compared with average daily volume of 11,687 shares in the past one quarter. The stock hit a high of Rs 584.70 and a low of Rs 558.80 so far during the day. The stock hit a 52-week high of Rs 640.90 on 21 October 2016. The stock hit a 52-week low of Rs 400.50 on 18 March 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, falling 5.43% compared with the 5.66% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 2.59% as against Sensexs 7.03% decline.

The mid-cap company has equity capital of Rs 68 crore. Face value per share is Rs 10.

Timken India engineers and manufactures bearings and mechanical power transmission components including gear drives, couplings, belts and chain.

Powered by Capital Market - Live News

Tata Steel edges higher in early trade
Nov 29,2016

The announcement was made after market hours yesterday, 28 November 2016.

Meanwhile, the S&P BSE Sensex was up 113.68 points or 0.43% at 26,463.85.

On BSE, so far 87,000 shares were traded in the counter as against average daily volume of 9.01 lakh shares in the past one quarter. The stock hit a high of Rs 417.35 and a low of Rs 414 so far during the day. The stock had hit a 52-week high of Rs 440.90 on 11 November 2016. The stock had hit a 52-week low of Rs 211.30 on 12 February 2016. The stock had outperformed the market over the past one month till 28 November 2016, gaining 0.66% compared with the Sensexs 5.7% fall. The scrip had also outperformed the market in past one quarter, advancing 10.07% as against the Sensexs 5.15% fall.

The large-cap company has equity capital of Rs 971.22 crore. Face value per share is Rs 10.

Tata Steel UK announced the signing of a letter of intent with Liberty House Group to enter into exclusive negotiations for the potential sale of its Speciality Steels business for an enterprise value of n++100 million subject to due diligence and corporate approvals. The letter of intent covers several South Yorkshire-based assets including the Rotherham electric arc steelworks, the steel purifying facility in Stocksbridge and a mill in Brinsworth as well as service centres in Bolton and Wednesbury, UK, and in Suzhou and Xian, China. Speciality Steels employs about 1,700 people making steels for the aerospace, automotive and the oil & gas industries.

Tata Steel UK has invested n++1.5 billion of capital over the last nine years. The companys boards consider the technical feasibility and economic returns of investments when taking decisions, as well as their affordability. The company is pursuing a transformation plan to create a sustainable future for its UK strip products business. The success of this plan is likely to influence decisions on future investments. In the current year, the company is pursuing n++85 million worth of capital investments covering a range of sustenance and improvement schemes.

On a consolidated basis, Tata Steel reported net loss of Rs 49.38 crore in Q2 September 2016, compared with net profit of Rs 5609.43 crore in Q2 September 2015. Net sales rose 0.1% to Rs 26291.86 crore in Q2 September 2016 over Q2 September 2015.

Tata Steel is Europes second largest steel producer, with steelmaking in the UK and Netherlands, and manufacturing plants across Europe. The combined Tata Steel group is one of the worlds largest steel producers.

Powered by Capital Market - Live News

Metal stocks shine on higher copper prices
Nov 28,2016

Jindal Steel & Power (up 6.54%), Hindustan Zinc (up 4.23%), JSW Steel (up 2.95%), Steel Authority of India (up 1.99%), Hindustan Copper (up 0.9%) and NMDC (up 0.49%) edged higher. National Aluminium Company (down 0.44%) and Hindalco Industries (down 0.94%) edged lower.

High Grade Copper for March 2017 delivery was currently up 1.01% at $2.7085 per pound on the COMEX.

Meanwhile, the S&P BSE Sensex was up 18.29 points or 0.07% at 26,334.63. The S&P BSE Metal index was currently up 0.92% at 10,618.75, outperforming the Sensex.

The BSE Metal index had outperformed the market over the past one month till 25 November 2016, advancing 2.23% compared with the Sensexs 6.32% fall. The index had also outperformed the market in past one quarter, gaining 6.44% as against the Sensexs 5.46% fall.

Tata Steel was down 0.17%. The company announced that the company at its meeting held on Friday, 25 November 2016, decided to convene an extraordinary general meeting (EGM) on 21 December 2016, pursuant to the special notice & requisition dated 10 November 2016, received from Tata Sons, promoter and principal shareholder of the company, holding 29.75% of the paid-up ordinary share capital of the company, to consider and if thought fit, to pass the resolutions viz. removal of C. P. Mistry as director of the company and removal of Nusli N. Wadia as director of the company. The announcement was made after market hours on Friday, 25 November 2016.

Vedanta rose 2.2% after the company announced that it proposes to offer rated secured redeemable non-convertible debentures aggregating upto Rs 500 crore and in this regard, the company is holding a meeting of its duly constituted committee of the board on 30 November 2016. The announcement was made after market hours on Friday, 25 November 2016.

Powered by Capital Market - Live News

Oil India declines after weak Q2 results
Nov 28,2016

The result was announced during trading hours today, 28 November 2016.

Meanwhile, the BSE Sensex was up 51.71 points, or 0.20%, to 26,368.05.

On BSE, so far 1.68 lakh shares were traded in the counter, compared with average daily volume of 71,901 shares in the past one quarter. The stock hit a high of Rs 444.95 and a low of Rs 426.05 so far during the day. The stock hit a 52-week high of Rs 446 on 24 November 2016. The stock hit a record low of Rs 300.50 on 1 March 2016. The stock had outperformed the market over the past 30 days till 25 November 2016, rising 5.99% compared with the 5.73% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.63% as against Sensexs 5.28% decline.

The large-cap company has equity capital of Rs 601.14 crore. Face value per share is Rs 10.

Meanwhile, the company announced in a separate announcement today, 28 November 2016, that its board recommended issuing one bonus equity share for every three existing fully paid up equity share (1:3). The proposal is subject to approval of the shareholders.

The Government of India held 67.64% stake in Oil India as per the shareholding pattern as on 30 September 2016.

Powered by Capital Market - Live News